OCREVUS

Hoffmann-La Roche Limited🇨🇦 Health Canada

Approval Id: 92541ddaaa5485fd
Drug Approval Canada Name: OCREVUS
Product Name: OCREVUS
Status: Marketed
Status Date: 2017-09-21
Original Market Date: 2017-09-21
Din: 02467224
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 92:20.00
Atc Original: L04AG08 OCRELIZUMAB
Atc Name: l 04 ag 08
Aig Number: 0159350001
Company Name: Hoffmann-La Roche Limited
Company Address: 7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8

OCRELIZUMAB

30 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

92541ddaaa5485fd

Type

Standard